brian d adams
Brain Institute of America
New Haven, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Brain Institute of America
New Haven, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
King Saud University
Riyadh, Saudi Arabia
Associate Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute (NIH)
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
United Arab Emirates University
Al-Ain, United Arab Emirates
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Texas Southwestern Medical Center
Dallas, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Toronto
Toronto, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Mysore
Mysore, India
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Medicine and Pharmacy Iuliu Hatieganu
Cluj-Napoca, Romania
Associate Editor
Cancer Molecular Targets and Therapeutics
Center for Cancer Research, National Cancer Institute (NIH)
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Thomas Jefferson University
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Molecular Targets and Therapeutics
Uniformed Services University of the Health Sciences
Bethesda, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Institute of Oncology Research (IOR)
Bellinzona, Switzerland
Associate Editor
Cancer Molecular Targets and Therapeutics
Department of Medical Oncology, Bern University Hospital
Bern, Switzerland
Associate Editor
Cancer Molecular Targets and Therapeutics
Texas A and M University
College Station, United States
Associate Editor
Cancer Molecular Targets and Therapeutics